LOGIN
Effect of Leukocyte-Reduced Platelet-Rich Plasma On Synovial Fluid Biomarkers After Pilon Fractures
May 2022
Effect of Leukocyte-Reduced Platelet-Rich Plasma On Synovial Fluid Biomarkers After Pilon Fractures
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A prospective randomized double-blind clinical trial to assess the effects of leukocyte-reduced platelet-rich plasma on pro-inflammatory, degradative, and anabolic biomarkers after closed pilon fractures.
J Orthop Res . 2022 Apr;40(4):925-932Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Eleven patients undergoing two-staged open reduction and internal fixation (ORIF) of an isolated pilon fracture were randomized to receive either 5ml of either autogenous leukocyte-reduce platelet-rich plasma (PRP) (n=5) or sterile 0.9% saline (n=6). The primary outcomes of this trial were to assess the number of post-traumatic osteoarthritis (PTOA)-related pro-inflammatory degradative biomarkers ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.